Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Inhalation
Sort By
Newest First
1 / 1
1 / 1
Inhalation Vaccines
The Exciting Potential of Inhalation Vaccines
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-11-022-NI-10
Nov 15, 2022
Cannabinoids
Kindeva and BOL Pharma Using Low Global Warming Potential (GWP) Propellant in Development of Inhaled Cannabinoid Products
Kindeva Drug Deliver
PR-M05-22-06
May 11, 2022
Respiratory Diseases
Developing a Novel Anti-Inflammatory for Patients with Severe Asthma
Robert Clarke, Ph.D
Kinaset Therapeutics
PAO-02-022-CL-13
Mar 12, 2022
Inhalation
Integrating Development and Manufacturing Experience with Inhalation Solutions
Recipharm AB
PAO-03-22-R250-02
Mar 01, 2022
Inhalation
Supporting Inhalation Development for Both Drugs and Devices
Vectura Group
PAO-04-22-R221-19
Apr 14, 2021
Inhalation Design
The Future of Inhalation
Vectura Group
PAO-04-22-R221-17
Apr 09, 2021
Formulation
Developing and Characterizing DPI Formulations for Biologics
Eunice Costa; Constança Cacela
Hovione
PAP-Q1-2019-CL-002
Apr 12, 2019
Inhalation
FDA Approves First Inhaler with Built-in Sensors
Emilie Branch
Pharma's Almanac
PAO-M01-19-NI-009
Jan 09, 2019
Inhalation
GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD
Emilie Branch
Pharma's Almanac
PAO-M05-18-NI-022
May 31, 2018
Inhalation
Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol
Teva Pharmaceutical Industries
PR-M02-18-NI-53
Feb 15, 2018
Clinical Trials
COPD Patients Excited about AstraZeneca Trial Results
Guy Tiene
Nice Insight
PAO-M02-18-NI-002
Feb 01, 2018
Inhalation
Hovione strengthens Inhalation Services portfolio
Hovione
PR-M01-18-NI-084
Jan 24, 2018
Formulation
Polyphor AG: Polyphor Launches the Development of an Inhaled Formulation of its Antibiotic Murepavadin
Polyphor
PR-M10-17-NI-004
Oct 13, 2017
Clinical Trials
AstraZeneca, Pieris Pharmaceuticals Join Forces to Combat Respiratory Diseases
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M05-17-NI-011
May 11, 2017
